N-((S)-CYCLOPROPYL-(1-(2,2-DIFLUOROETHYL)-5-FLUOROBENZIMIDAZOL-2-YL)METHYL)-5-(DIFLUOROMETHYL)PYRAZINE-2-CARBOXAMIDE
UNII 6KP8VF52JN
Substance Identification & Data
This profile provides standardized clinical and technical data for N-((s)-cyclopropyl-(1-(2,2-difluoroethyl)-5-fluorobenzimidazol-2-yl)methyl)-5-(difluoromethyl)pyrazine-2-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6KP8VF52JN.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3037243-77-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H16F5N5O SSLJYRIXLUPEFG-INIZCTEOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-((s)-cyclopropyl-(1-(2,2-difluoroethyl)-5-fluorobenzimidazol-2-yl)methyl)-5-(difluoromethyl)pyrazine-2-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.